Elena Shagisultanova

EGFR and RB1 as Dual Biomarkers in HPV-Negative Head and Neck Cancer

Tim N. Beck, Rachel Georgopoulos, Elena Shagisultanova et al. · Molecular Cancer Therapeutics · 2016 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +17

The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?

Jagar Jasem, Christine M. Fisher, Arya Amini et al. · Journal of the National Comprehensive Cancer Network · 2017 · 55 citations · Full text

Medicine, Oncology, Breast Oncology +11

Hypersensitivity of Tumor Cell Lines with Microsatellite Instability to DNA Double Strand Break Producing Chemotherapeutic Agent Bleomycin

Hai-Ri Li, Elena Shagisultanova, Kentaro Yamashita et al. · Cancer Research · 2004 · 48 citations

Life Sciences, Genetics, Oncology +17

Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer

Michelle Borakove, Yayi Feng, William M. Wuest et al. · Breast Cancer Research and Treatment · 2019 · 42 citations · Full text

Medicine, Oncology, Pharmacology +16

Overall survival is the lowest among young women with postpartum breast cancer

Elena Shagisultanova, Dexiang Gao, Eryn Callihan et al. · European Journal of Cancer · 2022 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17